New York Life Investment Management LLC Inhibrx, Inc. Transaction History

New York Life Investment Management LLC

  • $9.34 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024
BUY
$32.76 - $39.56 $1.34 Million - $1.62 Million
40,976 New
40,976 $1.43 Million
Q4 2022

Feb 10, 2023
BUY
$20.18 - $33.33 $57,896 - $95,623
2,869 Added 12.7%
25,458 $627,000
Q3 2022

Nov 10, 2022
BUY
$11.58 - $24.73 $19,199 - $41,002
1,658 Added 7.92%
22,589 $405,000
Q2 2022

Aug 12, 2022
BUY
$8.52 - $25.26 $178,332 - $528,717
20,931 New
20,931 $238,000

Others Institutions Holding INBX

# of Institutions
2
Shares Held
25.3K
Call Options Held
0
Put Options Held
0
View Full List

About Inhibrx, Inc.

INBX Quotes by TradingView
  • Ticker INBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,057,700
  • Market Cap $617M
  • Description
  • Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcin...
More about INBX
Track This Portfolio

Track New York Life Investment Management LLC Portfolio

Follow New York Life Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York Life Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on New York Life Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email